These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28025581)

  • 1. PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias.
    Ronchini C; Brozzi A; Riva L; Luzi L; Gruszka AM; Melloni GEM; Scanziani E; Dharmalingam G; Mutarelli M; Belcastro V; Lavorgna S; Rossi V; Spinelli O; Biondi A; Rambaldi A; Lo-Coco F; di Bernardo D; Pelicci PG
    Leukemia; 2017 Sep; 31(9):1975-1986. PubMed ID: 28025581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression.
    Wartman LD; Larson DE; Xiang Z; Ding L; Chen K; Lin L; Cahan P; Klco JM; Welch JS; Li C; Payton JE; Uy GL; Varghese N; Ries RE; Hoock M; Koboldt DC; McLellan MD; Schmidt H; Fulton RS; Abbott RM; Cook L; McGrath SD; Fan X; Dukes AF; Vickery T; Kalicki J; Lamprecht TL; Graubert TA; Tomasson MH; Mardis ER; Wilson RK; Ley TJ
    J Clin Invest; 2011 Apr; 121(4):1445-55. PubMed ID: 21436584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia.
    Le Beau MM; Davis EM; Patel B; Phan VT; Sohal J; Kogan SC
    Blood; 2003 Aug; 102(3):1072-4. PubMed ID: 12689927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
    Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
    Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia.
    Cole CB; Verdoni AM; Ketkar S; Leight ER; Russler-Germain DA; Lamprecht TL; Demeter RT; Magrini V; Ley TJ
    J Clin Invest; 2016 Jan; 126(1):85-98. PubMed ID: 26595813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
    Lou Y; Ma Y; Sun J; Ye X; Pan H; Wang Y; Qian W; Meng H; Mai W; He J; Tong H; Jin J
    Ann Hematol; 2015 Nov; 94(11):1829-37. PubMed ID: 26294332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
    Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
    Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA.
    Keeshan K; Vieugué P; Chaudhury S; Rishi L; Gaillard C; Liang L; Garcia E; Nakamura T; Omidvar N; Kogan SC
    Haematologica; 2016 Oct; 101(10):1228-1236. PubMed ID: 27390356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia.
    Chim CS; Wong SY; Pang A; Chu P; Lau JS; Wong KF; Kwong YL
    Leukemia; 2005 Dec; 19(12):2241-6. PubMed ID: 16239915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure.
    Nasr R; Lallemand-Breitenbach V; Zhu J; Guillemin MC; de Thé H
    Clin Cancer Res; 2009 Oct; 15(20):6321-6. PubMed ID: 19808868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of PML/RARa transcripts in acute promyelocytic leukemia by real-time quantitative reverse transcription polymerase chain reaction].
    Lang L; Li HM; Liu H; Wang YM; Zhang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):714-9. PubMed ID: 17708789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
    Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
    Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genomic landscape of core-binding factor acute myeloid leukemias.
    Faber ZJ; Chen X; Gedman AL; Boggs K; Cheng J; Ma J; Radtke I; Chao JR; Walsh MP; Song G; Andersson AK; Dang J; Dong L; Liu Y; Huether R; Cai Z; Mulder H; Wu G; Edmonson M; Rusch M; Qu C; Li Y; Vadodaria B; Wang J; Hedlund E; Cao X; Yergeau D; Nakitandwe J; Pounds SB; Shurtleff S; Fulton RS; Fulton LL; Easton J; Parganas E; Pui CH; Rubnitz JE; Ding L; Mardis ER; Wilson RK; Gruber TA; Mullighan CG; Schlenk RF; Paschka P; Döhner K; Döhner H; Bullinger L; Zhang J; Klco JM; Downing JR
    Nat Genet; 2016 Dec; 48(12):1551-1556. PubMed ID: 27798625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a 3-Plex RT-qPCR assay for the simultaneous detection and quantitation of the three PML-RARa fusion transcripts in acute promyelocytic leukemia.
    Chen Z; Tong Y; Li Y; Gao Q; Wang Q; Fu C; Xia Z
    PLoS One; 2015; 10(3):e0122530. PubMed ID: 25815789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL.
    Leiva M; Moretti S; Soilihi H; Pallavicini I; Peres L; Mercurio C; Dal Zuffo R; Minucci S; de Thé H
    Leukemia; 2012 Jul; 26(7):1630-7. PubMed ID: 22333881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity.
    Noguera NI; Piredda ML; Taulli R; Catalano G; Angelini G; Gaur G; Nervi C; Voso MT; Lunardi A; Pandolfi PP; Lo-Coco F
    Oncotarget; 2016 Oct; 7(41):66386-66397. PubMed ID: 27626703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation.
    Gaillard C; Tokuyasu TA; Rosen G; Sotzen J; Vitaliano-Prunier A; Roy R; Passegué E; de Thé H; Figueroa ME; Kogan SC
    Haematologica; 2015 Aug; 100(8):1064-75. PubMed ID: 26088929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.
    Jeanne M; Lallemand-Breitenbach V; Ferhi O; Koken M; Le Bras M; Duffort S; Peres L; Berthier C; Soilihi H; Raught B; de Thé H
    Cancer Cell; 2010 Jul; 18(1):88-98. PubMed ID: 20609355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML-RARA fusion resulting from a cryptic insertion of RARA gene into PML gene without the reciprocal RARA-PML fusion: clinical, cytogenetic, and molecular characterization and prognosis.
    Fan H; Ortega V; Fanasch HM; Wang Y; Holder KN; Higgins RA; Mendiola C; Mohamed G; Vadlamudi K; Velagaleti G
    Eur J Haematol; 2014 Oct; 93(4):354-8. PubMed ID: 24673420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.